French Family Group Invests in U.S. Biotechnology Company

July 25, 2017

Representation of Intralytix, Inc., a leader in bacteriophage technology, in connection with a $17.5 million equity investment by Lesaffre, a France-based manufacturer and marketer of innovative solutions for biotechnology.
Back to top